RA treatment study group: Improvement in RA management

Joint Bone Spine

Volumn 76, Issue 4, 2009, Pages 435-437

  Ward, Michael ^a   Liang, Matthew H ^b   Burns, Thomas ^c   Singh, Gurkirpal ^d  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti TNF drugs; Infections; Methotrexate; Orthopedics; Rheumatoid arthritis; Treatment strategy

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ETANERCEPT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RITUXIMAB; STEROID;

CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTIVE SURGERY; LOW DRUG DOSE; MORBIDITY; NARCOTIC DEPENDENCE; OUTCOME ASSESSMENT; REFRACTORY PERIOD; RHEUMATOID ARTHRITIS; SHORT SURVEY; TREATMENT RESPONSE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOLOGIC FACTORS; METHOTREXATE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67649967497     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2009.05.003     Document Type: Short Survey

References (6)

1. Jain A., Maini R., and Nanchahal J. Disease modifying treatment and elective surgery in rheumatoid arthritis: the need for more data. Ann Rheum Dis 63 (2004) 602-603
2. Bongartz T. Elective orthopedic surgery and perioperative DMARD management: many questions, fewer answers, and some opinions. J Rheumatol 34 (2007) 653-655
3. Talwalkar S.C., Grennan D.M., Gray J., et al. Tumour necrosis factor alpha antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery. Ann Rheum Dis 64 (2005) 650-651
4. Pham T., Claudepierre P., Deprez X., et al., Club Rhumatismes et Inflammation, French Society of Rheumatology. Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology. Joint Bone Spine 72 Suppl. 1 (2005 Jun) S1-58
5. del Rincon I., Freeman G.L., Haas R.W., et al. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 52 (2005) 3413-3423
6. Ridker P.M., Danielson E., Fonseca, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008) 2195-2207